Cargando…
The MHRA pharmacovigilance inspection programme: priorities and challenges
Autores principales: | Adams, Anna L, Trevett, Kiernan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842175/ https://www.ncbi.nlm.nih.gov/pubmed/35173951 http://dx.doi.org/10.1177/2042098619875317 |
Ejemplares similares
-
Pharmacovigilance inspections
por: Fitzgerald, Patricia
Publicado: (2008) -
Valproate MHRA Guidance: Limitations and Opportunities
por: Watkins, Lance, et al.
Publicado: (2019) -
Challenges in pharmacovigilance
por: Dikshit, R. K.
Publicado: (2010) -
Concerns raised with MHRA of anticoagulant use during pandemic
Publicado: (2020) -
MHRA COVID-19 website for reporting ADRs and incidents
Publicado: (2020)